MADISON TURNER: Open Payments
NPI 1164063418 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,490 in 74 payments from 15 companies in 2025. Trend: 2023 $1,730 · 2024 $1,159 · 2025 $1,490
Food & beverage: $1,490
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 12 | $291 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $234 |
| Alnylam Pharmaceuticals Inc. | 9 | $199 |
| Merck Sharp & Dohme LLC | 12 | $170 |
| Novo Nordisk Inc | 8 | $149 |
| Daiichi Sankyo Inc. | 6 | $105 |
| Novartis Pharmaceuticals Corporation | 5 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| AngioDynamics, Inc. | 2 | $39 |
Products named: General - Therapies, LifeVest, ONPATTRO, Wegovy, VERQUVO, INJECTAFER, LEQVIO, Kerendia.
Industry payments across OK — which companies pay providers there.
